These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28882566)

  • 1. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
    Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
    Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
    Ménard V; Eap O; Harvey M; Guillemette C; Lévesque E
    Hum Mutat; 2009 Sep; 30(9):1310-9. PubMed ID: 19572376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
    Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
    Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
    Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.
    Margaillan G; Lévesque É; Guillemette C
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):85-93. PubMed ID: 26385605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.
    Angstadt AY; Berg A; Zhu J; Miller P; Hartman TJ; Lesko SM; Muscat JE; Lazarus P; Gallagher CJ
    Cancer; 2013 Jul; 119(13):2477-85. PubMed ID: 23575887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
    Grant DJ; Hoyo C; Oliver SD; Gerber L; Shuler K; Calloway E; Gaines AR; McPhail M; Livingston JN; Richardson RM; Schildkraut JM; Freedland SJ
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):3-9. PubMed ID: 23098242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.
    Grant DJ; Chen Z; Howard LE; Wiggins E; De Hoedt A; Vidal AC; Carney ST; Squires J; Magyar CE; Huang J; Freedland SJ
    BMC Cancer; 2017 Jul; 17(1):463. PubMed ID: 28673330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
    Park JY; Tanner JP; Sellers TA; Huang Y; Stevens CK; Dossett N; Shankar RA; Zachariah B; Heysek R; Pow-Sang J
    Urology; 2007 Aug; 70(2):374-9. PubMed ID: 17826523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.
    Cai L; Huang W; Chou KC
    Protein Pept Lett; 2012 Jan; 19(1):62-9. PubMed ID: 21919858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number variations exploration of multiple genes in Graves' disease.
    Song RH; Shao XQ; Li L; Wang W; Zhang JA
    Medicine (Baltimore); 2017 Jan; 96(4):e5866. PubMed ID: 28121931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.
    Karypidis AH; Olsson M; Andersson SO; Rane A; Ekström L
    Pharmacogenomics J; 2008 Apr; 8(2):147-51. PubMed ID: 17387331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UGT2B17 gene deletion is not associated with prostate cancer risk.
    Olsson M; Lindström S; Häggkvist B; Adami HO; Bälter K; Stattin P; Ask B; Rane A; Ekström L; Grönberg H
    Prostate; 2008 Apr; 68(5):571-5. PubMed ID: 18247404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
    Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
    Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
    J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.
    Bhatt DK; Basit A; Zhang H; Gaedigk A; Lee SB; Claw KG; Mehrotra A; Chaudhry AS; Pearce RE; Gaedigk R; Broeckel U; Thornton TA; Nickerson DA; Schuetz EG; Amory JK; Leeder JS; Prasad B
    Drug Metab Dispos; 2018 Jun; 46(6):888-896. PubMed ID: 29602798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.